Gyre Therapeutics Inc.

NASDAQ: GYRE · Real-Time Price · USD
8.11
-0.11 (-1.34%)
At close: Aug 15, 2025, 3:59 PM
8.14
0.37%
After-hours: Aug 15, 2025, 04:04 PM EDT

Gyre Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
17.9M -85.48M 2.3M -87.93M
Depreciation & Amortization
1.59M 1.11M 1.13M 290K
Stock-Based Compensation
831K 7.28M 13.37M 3.4M
Other Working Capital
-4.02M 4.22M 1.11M -5.39M
Other Non-Cash Items
-7.27M 96.68M -337K 3.89M
Deferred Income Tax
-1M -1.16M -838K -3.89M
Change in Working Capital
-15.69M 7.46M -4.95M 483K
Operating Cash Flow
-3.64M 25.89M 10.68M -83.75M
Capital Expenditures
-2.31M -8.59M -5M -839K
Cash Acquisitions
n/a 4.02M 55.5M n/a
Purchase of Investments
-15.47M -15.73M -50.51M n/a
Sales Maturities Of Investments
n/a n/a 57.5M 49.03M
Other Investing Acitivies
-2.1M 471K -2.06M n/a
Investing Cash Flow
-19.88M -19.76M 55.43M 48.19M
Debt Repayment
n/a n/a -466.28K -6.7M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a -45.03M n/a
Other Financial Acitivies
1.33M n/a 486.28K 6.7M
Financial Cash Flow
2.1M 2.5M -45.01M 49.55M
Net Cash Flow
-21.7M 8.33M 25.18M 13.99M
Free Cash Flow
-5.96M 17.31M -38.09M -84.59M